<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>176</id><JournalTitle>INTRODUCTION TO THE CROSS-SECTIONAL STUDY OF TYPE 2 DIABETES MELLITUS AND MICROVASCULAR COMPLICATIONS: A CROSS-SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL</JournalTitle><Abstract>Type 2 diabetes mellitus (T2DM) is a worldwide epidemic and India has second largest burden of diabetes
in the world. Microvascular complications, such as retinopathy, nephropathy and neuropathy, can occur at diagnosis and
are evidence of years of unnoticed hyperglycaemia. Knowing the metabolic and microvascular burden at the first
diagnosis is crucial for early targeted intervention.Methods: A cross sectional study was carried out by enrolling 300 drug
naïve adults with newly diagnosed T2DM (A1C ? 6.5% at the time of diagnosis <6 months).Comprehensive glycaemic
profiling (FPG, PPPG, HbA1c), fasting lipid profile, spot urinary albumin-creatinine ratio (ACR), fundus photography for
diabetic retinopathy (DR), biothesiometry/10-g monofilament for peripheral neuropathy, and eGFR were performed.
Patients were stratified by HbA1c: <8%, 8–9.9%, and ?10%.Results: Mean HbA1c was 9.4 ± 2.1%. Dyslipidaemia was
present in 71.0% (hypertriglyceridaemia 48.0%, low HDL 56.0%). Any microvascular complication was detected in
36.7%: albuminuria 22.0%, retinopathy 14.0%, peripheral neuropathy 31.3%. The prevalence of all microvascular
complications rose significantly with HbA1c ?10%. In multivariable analysis, HbA1c ?10%, central obesity (waist ?90
cm in men, ?80 cm in women), and hypertriglyceridaemia were independent predictors of microvascular
complications.Conclusion: A substantial proportion of newly diagnosed T2DM patients already harbour microvascular
complications, underscoring the 'ticking-clock' phenomenon of pre-diagnostic hyperglycaemia. Simultaneous metabolic
and microvascular evaluation at the time of diagnosis and early multifactorial intervention are essential</Abstract><Email>-</Email><articletype>Research</articletype><volume>9</volume><issue>2</issue><year>2019</year><keyword>Type 2 diabetes mellitus; newly diagnosed; HbA1c; microvascular complications; diabetic retinopathy; diabetic nephropathy; diabetic neuropathy; dyslipidaemia; India</keyword><AUTHORS>Dr. Sridhar Pilla Dr. Sridhar Pilla</AUTHORS><afflication>Assistant Professor, Department of General Medicine, Aarupadai Veedu Medical College and Hospital, Kirumampakkam, Bahour Commune Panchayat, Puducherry – 607402 2Assistant Professor, Department of Pharmacology, Tagore Medical College and Hospital, Chennai </afflication></Article></Articles>